Molecular markers of the risk of development of skin cancer in psoriasis patients receiving a phototherapy

Cover Page


Cite item

Full Text

Abstract

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation Korolenko str., 3, bldg 6, Moscow, 107076, Russia Goal. To study potential molecular and genetic markers of an increased risk of development of malignant skin melanomas on the basis of the assessment of nucleotide replacements of genes in the excision system of DNA repair in psoriasis patients receiving a phototherapy. Materials and methods. Biological blood samples taken from 47 psoriasis patients, 24 patients with malignant skin melanomas and 20 healthy subjects. The following methods were used in the study: clinical, molecular and biological (DNA extraction, amplification, PcR, sequencing). Results. The study revealed molecular markers of an increased risk of development of malignant skin melanomas in psoriasis patients: CC genotype of the XPD gene at the 35931 locus (p = 0.00001); TC genotype of the XPF gene at the 27945 locus (p = 0.0067). It also revealed a molecular marker of an increased risk of development of malignant skin melanomas in healthy people: CC genotype of the XPD gene at the 35931 locus (p = 0.0042).

About the authors

M. B. Zhilova

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: zhilova@cnikvi.ru
Russian Federation

A. A. Kubanov

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
Russian Federation

References

  1. Chen Y.J., Wu C.Y., Chen T.J., et al. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan. J Am Acad Dermatol 2011; 65: 84-91.
  2. Bergner T., Przybilla B. Malignant melanoma in association with phototherapy. Dermatology 1992; 184 (1): 59-61.
  3. D. Kemmett, H. Reshad, and H. Baker Nodular malignant melanoma and multiple squamous cell carcinomas in a patient treated by photochemotherapy for psoriasis. Br Med J (Clin Res Ed). 1984; Dec 1, 289 (6457): 1498.
  4. Azoury S.C., Lange J.R. Epidemiology, Risk Factors, Prevention, and Early Detection of Melanoma. Surg Clin North Am. 2014 Oct; 94 (5): 945-962.
  5. Reichrath J., Reichrath S. Sunlight, vitamin D and malignant melanoma: an update. Adv Exp Med Biol 2014; 810: 390-405.
  6. Moan J.E., Baturaite Z., Dahlback A., Porojnicu A.C. Ultraviolet radiation and cutaneous malignant melanoma. Adv Exp Med Biol 2014; 810: 359-74.
  7. Marx J.L., Auerbach R., Possick P., Myrow R., Gladstein A.H., Kopf A.W. Malignant melanoma in situ in two patients treated with psoralens and ultraviolet A. J Am Acad Dermatol 1983 Dec; 9 (6): 904-11.
  8. Alcalay J., Bucan C., Kripke M.L. Cutaneous pigmented melanocytic tumor in a mouse treated with psoralen plus ultraviolet A radiation. Photodermatol Photoimmunol Photomed 1990; 7: 28-31.
  9. Aubin F., Donawho C.K., Kripke M.L. Effect of psoralen plus ultraviolet A radiation on in vivo growth of melanoma cells. Cancer Res 1991; 51: 5893-5897.
  10. Brenner A.V., Lubin J.H., Calista D., Landi M.T. Instrumental measurements of skin color and skin ultraviolet light sensitivity and risk of cutaneous malignant melanoma: a case-control study in an Italian population. Am J Epidemiol 2002; 156: 353-362.
  11. Tabenkin H., Tamir A., Sperber A.D., Shapira M., Shvartzman P. A case-control study of malignant melanoma in Israeli Kibbutzin. Isr Med Assoc J 1999; 1: 154-157.
  12. Wang S.Q., Setlow R., Berwick M., Polsky D., Marghoob A.A., Kopf A.W., Bart R.S. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001 May; 44 (5): 837-46.
  13. Sancar A. DNA repair in human. Annu Rev Genet 1995; 29: 69-105.
  14. Grossman L., Wei Q. DNA repair and epidemiology of basal cell carcinoma. Clin Chem 1995; 41: 1854-63.
  15. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A 1993; 90: 1614-8.
  16. Kraemer K.H. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer.The xeroderma pigmentosum paradigm. K.H. Kraemer, M.M. Lee, A.D. Andrews, W.C. Lambert. Arch Dermatol 1994; 130: 1018-1021.
  17. Setlow R.B. Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. R.B. Setlow, J.D. Regan, J. German et al. Proc Natl Acad Sci USA 1969; 64: 1035-1041.
  18. Dybdahl M. Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients. M. Dybdahl, G. Frentz, U. Vogel, H. Wallin, B.A. Nexo. Mutat Res 1999; 433: P. 15-22.
  19. Winsey S.L. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. S.L. Winsey, N.A. Haldar, H.P. Marsh et al. Cancer Res 2000; 60: 5612-5616.
  20. Qiao Y. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Y. Qiao, M.R. Spitz, H. Shen et al. Carcinogenesis 2002; 23: 295-299.
  21. Baccarelli A. XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk / A. Baccarelli, D. Calista, P. Minghetti et al. Br J Cancer 2004; 90: 497-502.
  22. Tomescu D. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma / D. Tomescu, G. Kavanagh, T. Ha, H. Campbell, D.W. Melton. Carcinogenesis 2001; 22: 403-408.
  23. Applebaum K.M. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and nonmelanoma skin cancer in New Hampshire. K.M. Applebaum, M.R. Karagas, D.J. Hunter, P.J. Catalano, S.H. Byler, S. Morris, H.H. Environ Health Perspect 2007; 115 (8): 231-236.
  24. Bishop S.C. DNA repair synthesis in human skin exposed to ultraviolet radiation used in PUVA (psoralen and UV-A) therapy for psoriasis. S.C. Bishop. Br J Dermatol 1979; 101 (4): 399-405.
  25. Bishop C. DNA Repair Elicited by UVB During PUVA Therapy for Psoriasis. C. Bishop and E. Abel. Arch Dermatol Res 1985; 278: 25-30.
  26. Cleaver J.E. A Summary of Mutations in the UV-Sensitive Disorders: Xeroderma Pigmentosum, Cockayne Syndrome, and Trichothiodystrophy. J.E. Cleaver, L.H. Thompson, A.S. Richardson, J.C. States. HUMAN MUTATION 1999; 14: 9-22.
  27. Li L. Characterization of molecular defects in Xeroderma pigmentosum group C. L. Li, E.S. Bales, C.A. Peterson, R.J. Legerski. Nat. Genet 1993; 5: 413-417.
  28. Povey J.E. et al. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis 2007; 28 (5): 1087-1093.
  29. Shen H., Xu Y., Qian Y., Yu R., Qin Y., Wang X., Spitz M., Wei Q. Polymorphisms of the DNA repair gene XRCC1 and risk of cancer in a Chinese population. Int J Cancer 2000; 88: 601-606,
  30. Kertat K., Rosdahl I., Sun X.F., Synnerstad I., Zhang H. The Gln/Gln genotype of XPD codon 751 as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: a case control study in the Swedish population. Oncol Rep 2008 Jul; 20 (1): 179-83.
  31. Ahmad A., Enzlin J.H., Bhagwat N.R., Wijgers N., Raams A., Appledoorn E., Theil A.F., J Hoeijmakers J.H., Vermeulen W., J Jaspers N.G., Schärer O.D., Niedernhofer L.J. Mislocalization of XPF, ERCC1 nuclease contributes to reduced DNA repair in XP-F patients. PLoS Genet 2010 Mar 5; 6 (3): e1000871.
  32. Mocellin S., Verdi D., Nitti D. DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review. and meta-analysis. Carcinogenesis 2009; 30 (10): 1735-1743.
  33. Zhu H.L., Bao J.M., Lin P.X., Li W.X., Zou Z.N., Huang Y.E., Chen Q., Shen H. XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a meta-analysis of 17 case-control studies. Asian Pac J Cancer Prev. 2014; 15 (16): 6619-25.
  34. Kertat K., Rosdahl I., Sun X.F., Synnerstad I., Zhang H. The genotype of as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: a case control study in the Swedish population. Oncol Rep 2008 Jul; 20 (1): 179-83.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Zhilova M.B., Kubanov A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies